[APLS] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
31-Jul-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -40.57%
YoY- -113.27%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 16,322 623 0 0 0 0 0 -
PBT -155,491 -219,191 -118,617 -71,090 -33,334 -12,126 -6,647 69.07%
Tax 486 3,706 6,914 388 -33,669 -12,138 38 52.89%
NP -155,977 -219,191 -118,617 -71,090 -33,334 -12,126 -6,647 69.16%
Tax Rate - - - - - - - -
Total Cost 172,299 219,814 118,617 71,090 33,334 12,126 6,647 71.98%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -955.62 -35,183.15 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.46 -2.72 -1.57 -1.12 -0.61 -0.67 -0.79 10.77%
EPS Diluted -1.46 -2.72 -1.57 -1.12 -0.61 -0.67 -0.79 10.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.